Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Buti

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening RateLaia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
JHEP Reports : Innovation in Hepatology|September 25, 2023
HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriersLuisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2026
Corrigendum to: "HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers" [JHEP Reports 5 (2023) 100842]Luisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, et al.
Medicina Clinica|March 3, 2009
[Diagnosis and treatment of hepatocellular carcinoma]Alejandro Forner, Carmen Ayuso, María Isabel Real, et al.
World Journal of Gastroenterology|October 15, 2013
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from ArgentinaNoemí del Pino, José Raúl Oubiña, Francisco Rodríguez-Frías, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 14, 2025
Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg-Negative Caucasian PatientsAnna Pocurull, Teresa Broquetas, Elena Hoyas, et al.
BMC Infectious Diseases|September 5, 2018
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virusMaría Eugenia Soria, Josep Gregori, Qian Chen, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective studyElena Vargas-Accarino, Ariadna Rando-Segura, Adriana Palom, et al.
Pathogens (Basel, Switzerland)|March 26, 2025
Improving HCV Screening in Addiction Care Centers with Plasma Separation CardsFernando Velásquez Orozco, David Tabernero, María Gabriela Barbaglia, et al.
Therapeutic Advances in Gastroenterology|September 2, 2021
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized managementLara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening RateLaia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
JHEP Reports : Innovation in Hepatology|September 25, 2023
HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriersLuisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2026
Corrigendum to: "HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers" [JHEP Reports 5 (2023) 100842]Luisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, et al.
Medicina Clinica|March 3, 2009
[Diagnosis and treatment of hepatocellular carcinoma]Alejandro Forner, Carmen Ayuso, María Isabel Real, et al.
World Journal of Gastroenterology|October 15, 2013
Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from ArgentinaNoemí del Pino, José Raúl Oubiña, Francisco Rodríguez-Frías, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 14, 2025
Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg-Negative Caucasian PatientsAnna Pocurull, Teresa Broquetas, Elena Hoyas, et al.
BMC Infectious Diseases|September 5, 2018
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virusMaría Eugenia Soria, Josep Gregori, Qian Chen, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective studyElena Vargas-Accarino, Ariadna Rando-Segura, Adriana Palom, et al.
Pathogens (Basel, Switzerland)|March 26, 2025
Improving HCV Screening in Addiction Care Centers with Plasma Separation CardsFernando Velásquez Orozco, David Tabernero, María Gabriela Barbaglia, et al.
Therapeutic Advances in Gastroenterology|September 2, 2021
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized managementLara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, et al.
Pageof 10